期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
地西他滨治疗骨髓增生异常综合征的疗效及其对血清LIF、TIM-3、TK-1水平的影响 被引量:5
1
作者 朱聪惠 陈任安 乔丹 《检验医学与临床》 CAS 2021年第24期3565-3567,3570,共4页
目的探讨地西他滨治疗骨髓增生异常综合征的疗效及其对血清白血病抑制因子(LIF)、T细胞免疫球蛋白黏蛋白分子3(TIM-3)、胸苷激酶1(TK-1)水平的影响。方法将2017年1月至2020年1月于该院治疗的68例骨髓增生异常综合征患者纳入研究,随机分... 目的探讨地西他滨治疗骨髓增生异常综合征的疗效及其对血清白血病抑制因子(LIF)、T细胞免疫球蛋白黏蛋白分子3(TIM-3)、胸苷激酶1(TK-1)水平的影响。方法将2017年1月至2020年1月于该院治疗的68例骨髓增生异常综合征患者纳入研究,随机分为对照组和研究组,各34例。对照组以高三尖杉酯碱+阿糖胞苷(HA)方案治疗,研究组在对照组治疗方案的基础上加用地西他滨治疗。对两组患者的疗效、药物不良反应进行分析,比较两组治疗前后的血清LIF、TIM-3、TK-1水平与血常规指标。结果研究组疾病控制率高于对照组(P<0.05)。对照组与研究组药物不良反应发生率比较差异无统计学意义(P>0.05)。治疗前,对照组与研究组血清LIF、TIM-3、TK-1水平比较,差异均无统计学意义(P>0.05);治疗后,研究组血清LIF水平高于对照组(P<0.05),TIM-3、TK-1水平低于对照组(P<0.05)。治疗前,对照组与研究组血常规指标比较,差异均无统计学意义(P>0.05);治疗后,研究组血红蛋白、血小板计数高于对照组(P<0.05),白细胞计数低于对照组(P<0.05)。结论以HA方案联合地西他滨治疗骨髓增生异常综合征患者可提升疗效,改善血清LIF、TIM-3、TK-1水平及血常规指标,药物不良反应发生率没有增加,建议临床推广使用。 展开更多
关键词 地西他滨 骨髓增生异常综合征 疗效 血清白血病抑制因子 T细胞免疫球蛋白黏蛋白分子3 胸苷激酶1
下载PDF
Development of a Synthetic Medium for the in Vitro Culture of Bovine Embryos
2
作者 Moreno D. Neira A. +5 位作者 Dubreil L. Liegeois L. Destrumelle S. Briand-Amirat L. Bencharif D. Tainturier D. 《Journal of Agricultural Science and Technology(A)》 2014年第8期679-685,共7页
The aim of this study was to develop a synthetic medium for the in vitro culture of bovine embryos, using various growth factors and cytokines (GF-CYK): insulin-like growth factorl (IGF-Ⅰ), insulin-like growth f... The aim of this study was to develop a synthetic medium for the in vitro culture of bovine embryos, using various growth factors and cytokines (GF-CYK): insulin-like growth factorl (IGF-Ⅰ), insulin-like growth factorⅡ (IGF-Ⅱ), basic fibroblast growth factor (bFGF), leukemia inhibitory factor (LIF), granulocyte-macrophage colony stimulating factor (GM-CSF) and transforming growth factor beta Ⅰ (TGF-β1) + hyaluronan (HA) + recombinant albumin (RA). The embryos were cultured in synthetic oviduct fluid (SOF) supplemented with: treatment 1 (T1): bovine serum albumin (BSA) + insulin, transferrin and selenium (ITS) (control); or treatment 2 (T2): GF-CYK + HA + RA. The blastocyst rates were not significantly different between TI and T2, at seven days post fertilization (dpf) (28.9% ± 2.4% and 31.8% ±2.2%), and at 8 dpf (36.5% ±2.4% and 39.1% ±1.9%), respectively (P 〉 0.05). The total cell number (TCN) was significantly higher with T2 than that with T1 at 7 dpf(164.9 ±5.3 and 149.7 ±4.0) and 8 dpf (182.7 ±6.4 and 165.0 ±5.5) (P 〈 0.05). The blastocyst diameter obtained with T2 was significantly greater (P 〈 0.05) than with T1 at 7 dpf (173.3 μm ±4.9 μm and 157.2μm ±4.1 μm, respectively), however, no significant differences were observed at 8 dpf (190.3 μm 5.2 μm and 179.7 μm ± 5.3 μm, respectively). In conclusion, the synthetic medium (T2) shows a comparable development rate to the control medium and improves the blastocyst diameter and the TCN. 展开更多
关键词 Growth factors CYTOKINES synthetic media.
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部